Ionis Pharmaceuticals Inc
NASDAQ:IONS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ionis Pharmaceuticals Inc
NASDAQ:IONS
|
US |
|
China Renaissance Holdings Ltd
HKEX:1911
|
CN |
|
C
|
Central Garden & Pet Co
SWB:GP7
|
US |
|
V
|
Victory Square Technologies Inc
CNSX:VST
|
CA |
|
E
|
Electricite de France SA
XHAM:E2F
|
FR |
|
N
|
Nike Inc
XBER:NKE
|
US |
|
H
|
HomeChoice International PLC
JSE:HIL
|
MT |
|
W
|
WEX Inc
F:WL9
|
US |
|
A
|
American Express Co
XHAM:AEC1
|
US |
|
JX Luxventure Ltd
NASDAQ:JXJT
|
CN |
|
Starcom Information Technology Ltd
BSE:531616
|
IN |
|
B
|
BDO Unibank Inc
XPHS:BDO
|
PH |
|
Linamar Corp
TSX:LNR
|
CA |
|
B
|
Basler AG
SWB:BSL
|
DE |
|
S
|
Solaredge Technologies Inc
LSE:0L7S
|
IL |
|
C
|
CVS Group PLC
XBER:4C9
|
UK |
|
C
|
Clemondo Group AB (publ)
STO:CLEM
|
SE |
Bankruptcy Probability
Ionis Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Ionis Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Ionis Pharmaceuticals Inc
NASDAQ:IONS
|
12.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
391.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
184.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
155.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
116.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
64.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Ionis Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Ionis Pharmaceuticals Inc has total debt of 1.9B USD. This includes both short-term (0 USD) and long-term (1.9B USD) debt.
You can find a full breakdown on its Balance Sheet.
